Cardiovascular diseases Trials in Minneapolis, United States
Conditions / Cardiovascular diseases / Minneapolis, United States
Clinical trials for Cardiovascular diseases investigate a range of treatment strategies and patient populations.
42 total trials for this combination
Showing top 10 of 42 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT01471522 | International Study of Comparative Health Effectiveness With Medical and Invasive Approaches (ISCHEMIA) | COMPLETED | NA |
| NCT00122993 | Worksite Program to Prevent Weight Gain Among Bus Drivers | COMPLETED | NA |
| NCT01687998 | A Study of Evacetrapib in High-Risk Vascular Disease | TERMINATED | PHASE3 |
| NCT00000620 | Action to Control Cardiovascular Risk in Diabetes (ACCORD) | COMPLETED | PHASE3 |
| NCT02993406 | Evaluation of Major Cardiovascular Events in Participants With, or at High Risk for, Cardiovascular Disease Who Are Statin Intolerant Treated With Bempedoic Acid (ETC-1002) or Placebo | COMPLETED | PHASE3 |
| NCT06526195 | Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure | RECRUITING | NA |
| NCT00324350 | Intensive Glycemic Control and Skeletal Health Study | COMPLETED | PHASE3 |
| NCT00039975 | Interactions Between HIV Protease Inhibitors and Calcium Channel Blockers | COMPLETED | PHASE1 |
| NCT00120289 | Niacin Plus Statin to Prevent Vascular Events | TERMINATED | PHASE3 |
| NCT00153101 | Effectiveness and Safety of Ramipril Alone Compared With Telmisartan Alone and in Combination With Ramipril in Patients at High Risk for Cardiovascular Events. Patients Intolerant to Ramipril Were Entered in TRANSCEND, Telmisartan Compared to Placebo. | COMPLETED | PHASE4 |